Our xTAG® and MultiCode®-RTx Technologies serve a wide range of clinical applications, providing exceptional sensitivity and specificity, unmatched throughput flexibility, and increased assay speed.
Read More
Our xMAP® Technology and its flexible, open-architecture design is used in a wide variety of applications, from academic and clinical research to biodefense and clinical diagnostics.
Read More
Our Business Development team invites you to contact them to explore your potential development and commercialization applications using our xMAP® technology. Click here to start the conversation now.
Learn More
ARIES® System Provides Excellent Sensitivity and Specificity for HSV 1&2 Testing
“Mayo Clinic study compares ARIES® HSV 1&2 Assay with Roche and Hologic assays/platforms
A new publication from scientists at the Mayo Clinic reports results of the first comparison of three automated molecular diagnostic platforms for detecting and differentiating herpes simplex virus types 1 and 2. We were pleased to see that the ARIES® System was included and delivered the best combination of sensitivity and specificity…”
Continue Reading…
At Luminex, our mission is to empower labs to obtain reliable, timely, and actionable answers, ultimately advancing health.
Watch more videos >
April 20
Luminex Corporation To Present At Bank Of America Merrill Lynch 2017 Health Care Conference
April 10
Luminex Corporation First Quarter Earnings Release Scheduled for May 1, 2017
March 1
Luminex Corporation To Present At The Barclays Global Healthcare Conference
February 21
Luminex Corporation Announces Initiation of Cash Dividend
February 6
Luminex Corporation Reports Fourth Quarter And Full Year 2016 Results
ASCLS-MI
April 18-21
Kalamazoo, MI
ECCMID
April 22-25
Vienna, Austria
Nebraska Spring Laboratory Meeting
April 26
Ashland, NE
Annual Biomedical Research and Supplies Exhibit
May 2-3
Fort Detrick, MD
Ohio Collaborative Laboratory Conference
May 3-5
Columbus, OH
